Beskrivelse
In a moment of serendipity, two then unknown chemists conversing in a pub laid the groundwork for a genomics revolution, dramatically reducing sequencing time and costs. The innovation of Professor Sir David Klenerman and Sir Shankar Balasubramanian not only paves the way for personalised healthcare but also deepens understanding of human diversity and disease, showcasing the profound impact of curiosity-driven research in the scientific world. They are receiving the 2024 Novo Nordisk Prize their efforts.
